Tuesday, November 27, 2018

Zimmer Biomet initiated at UBS


Zimmer Biomet initiated with a Buy at UBS. UBS analyst Matthew Taylor initiated Zimmer Biomet with a Buy rating and $140 price target.
at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.